Lymphoid/nonlymphoid compartmentalization of donor leukocyte chimerism in rat recipients of heart allografts, with or without adjunct bone marrow

Transplantation

Volumn 66, Issue 3, 1998, Pages 350-357

  Terakura, Masanobu ^a   Murase, Noriko ^a   Demetris, Anthony J ^b   Ye, Qing ^a   Thomson, Angus W ^a   Starzl, Thomas E ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; LISOFYLLINE; SCATTER FACTOR; TACROLIMUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BLOOD SAMPLING; BONE MARROW; CELL MIGRATION; CHIMERA; DNA DETERMINATION; GRAFT REJECTION; HEART GRAFT; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SEX DETERMINATION;

EID: 0032529470     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199808150-00012     Document Type: Article

References (54)

1. Nemlander A, Soots A, Willebrand EV, Husberg B, Hayry P. Redistribution of renal allograft responding leukocytes during rejection. II. Kinetics and specificity. J Exp Med 1982; 156: 1087.
2. Larsen CP, Morris PJ, Austyn JM. Migration of dendritic leukocytes from cardiac allografts into host spleens: a novel route for initiation of rejection. J Exp Med 1990; 171: 307.
3. Demetris AJ, Qian S, Sun H, et al. Early events in liver allograft rejection: delineation of sites of simultaneous intragraft and recipient lymphoid tissue sensitization. Am J Pathol 1991; 138: 609.
4. Starzl TE, Zinkernagel R. The regulation of immune reactivity by antigen migration and localization: a comparison of "tolerance" to infectious agents and allografts. N Engl J Med (in press).
5. Murase N, Starzl TE, Ye Q, et al. Multilineage hematopoietic reconstitution of supralethally irradiated rats by syngeneic whole organ transplantation: with particular reference to the liver. Transplantation 1996; 61: 1.
6. Taniguchi H, Toyoshima T, Fukao K, Nakauchi H. Presence of hematopoietic stem cells in the adult liver. Nat Med 1996; 2: 198.
7. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992; 339: 1579.
8. Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993; 17: 1127.
9. Starzl TE, Demetris AJ, Trucco M, et al. Chimerism after liver transplantation for type IV glycogen storage disease and type I Gaucher's disease. N Engl J Med 1993; 328: 745.
10. Murase N, Starzl TE, Tanabe M, et al. Variable chimerism, graft versus host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to Brown-Norway rats. Transplantation 1995; 60: 158.
11. Demetris AJ, Murase N, Ye Q, et al. Analysis of chronic rejection and obliterative arteriopathy: possible contributions of donor antigen-presenting cells and lymphatic disruption. Am J Pathol 1997; 150(2): 563.
12. Lyman SD, Brasel K, Rousseau AM, Williams DE. The flt3 ligand: a hematopoietic stem cell factor whose activities are distinct from steel factor. [Review]. Stem Cells 1994; 12 (suppl 1): 99 (discussion, 108).
13. Skelly SM, Tackney C, Hicklin D, et al. High-level expression of a biologically active human interleukin-6 mutein. J Biotechnol 1994; 34: 79.
14. Singer JW, Burstein SL, Rice GC, Gordon WP, Bianco JA. Inhibitors of intracellular phosphatidic acid production: novel therapeutics with broad clinical applications. Exp Opin Invest Drugs 1994; 3: 631.
15. Foster PF, Kociss K, Shen J, et al. Granulocyte colony-stimulating factor immunomodulation in the rat cardiac transplantation model. Transplantation 1996; 61: 1122.
16. Murase N, Ye Q, Sakamoto T, et al. Effect in supralethally irradiated rats of granulocyte colony-stimulating factor and lisofylline on hematopoietic reconstitution by syngeneic bone marrow or whole organ passenger leukocytes. Transplantation 1997; 63: 1840.
17. Blin N, Stafford DW. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res 1976; 3: 2303.
18. Tashiro H, Fukuda Y, Kimura A, et al. Monitoring for rejection and engraftment by means of polymerase chain reaction after rat orthotopic liver transplantation. Transplantation 1994; 58: 745.
19. Bishop GA, Sung J, Decruz DJ, et al. Tolerance to rat liver allografts. III. Donor cell migration and tolerance-associated production in peripheral lymphoid tissues. J Immunol 1996; 156: 4925.
20. Bishop AG, Sun J, Sheil AGR, McCaughan GW. High-dose/activation-associated tolerance. Transplantation 1997; 64: 1377.
21. Qian S, Lu L, Fu F, et al. Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol 1997; 158: 4654.
22. Wood K, Sachs DH. Chimerism and transplantation tolerance: cause and effect. Immunol Today 1996; 17: 584.
23. Starzl TE, Demetris AJ, Trucco M, et al. Systemic chimerism in human female recipients of male livers. Lancet 1992; 340: 876.
24. Starzl TE, Demetris AJ, Trucco M, et al. Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation 1993; 55: 1272.
25. Suberbielle C, Caillat-Zucman S, Legendre C, et al. Peripheral microchimerism in long-term cadaveric kidney allograft recipients. Lancet 1994; 343: 1468.
26. Ishida H, Kawai T, Tanabe K, et al. Status of microchimerism in recipients 15 years after living related kidney transplantation. Transplantation 1996; 62: 126.
27. Elwood ET, Larsen CP, Maurer DH, et al. Microchimerism and rejection in clinical transplantation. Lancet 1997; 349: 1358.
28. Norris S, Lawler M, McCann S, Hegarty J, O'Farrelly C. Donor type microchimerism is an infrequent event following liver transplantation and is not associated with graft acceptance. Hepatology 1997; 26: 848.
29. Ricordi C, Karatzas T, Nery J, et al. High-dose donor bone marrow infusions to enhance allograft survival. Transplantation 1997; 63: 7.
30. Jonsson JR, Hogan PG, Thoma R, et al. Peripheral blood chimerism following human liver transplantation. Hepatology 1997; 25: 1233.
31. Bushell A, Pearson TC, Morris PJ, Wood KJ. Donor-recipient microchimerism is not required for tolerance induction following recipient pretreatment with donor specific transfusion and anti-CD4 antibody. Transplantation 1995; 59: 1367.
32. Shirwan H, Wang HK, Barwari L, Makowka L, Cramer DV. Pretransplant injection of allograft recipients with donor blood or lymphocytes permits allograft tolerance without the presence of persistent donor microchimerism. Transplantation 1996; 61: 1382.
33. Frede SE, Levy AE, Alexander JW, Babcock GF. An examination of tissue chimerism in the ACI to Lewis rat cardiac transplant model. Transplant Immunol 1996; 4: 227.
34. Shirwan H, Wu GD, Barwari L, Liu A, Cramer DV. Induction of allograft nonresponsiveness after intrathymic inoculation with donor class I allopeptides. II. Evidence for persistent chronic rejection despite high levels of donor microchimerism. Transplantation 1997; 64: 1671.
35. Murase N, Kim DG, Todo S, Cramer DV, Fung JJ, Starzl TE. FK 506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rat. Transplantation 1990; 50: 739.
36. Qian S, Demetris AJ, Murase N, Rao AS, Fung JJ, Starzl TE. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 1994; 19: 916.
37. Starzl TE, Demetris AJ, Murase N, Trucco M, Thomson AW, Rao AS. The lost chord: microchimerism. Immunol Today 1996; 17: 577.
38. Schlitt HJ, Hundrieser J, Ringe B, Pichlmayr R. Donor-type microchimerism associated with graft rejection eight years after liver transplantation. N Engl J Med 1994; 330: 646.
39. Molleston JP, Alevy YG, Sivasai KSR, Mohanakumar T, Howard TK. Evidence that pediatric liver transplant recipients may undergo late rejection episodes in spite of donor-specific microchimerism. Transplantation 1996; 61: 656.
40. Sivasai KSR, Alevy YG, Duffy BF, et al. Peripheral blood microchimerism in human liver and renal transplant recipients. Transplantation 1997; 64: 427.
41. Anand AC, Hubscher SG, Gunson BK, McMaster P, Neuberger JM. Timing, significance, and prognosis of late acute liver allograft rejection. Transplantation 1995; 60: 1098.
42. Talmage DW, Dart G, Radovich J, Lafferty KJ. Activation of transplant immunity: effect of donor leukocytes on thyroid allograft rejection. Science 1976; 191; 385.
43. Lafferty KJ, Prowse SJ, Simeonovic CJ. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol 1983; 1: 143.
44. Starzl TE, Rao AS, Thomson AW, Murase N, Demetris AJ. Donor-recipient microchimerism and tolerance induction. Transplantation 1996; 61: 169.
45. Monaco AP, Wood ML. Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum. Transplant Proc 1970; 2: 489.
46. Thomas J, Carver M, Foil B, Haisch C, Thomas F. Renal allograft tolerance induced with ATG and donor bone marrow in outbred rhesus monkeys. Transplantation 1983; 36: 104.
47. Barber WH, Mankin JA, Laskow DA, et al. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 1991; 51: 70.
48. Lieschke GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2). N Engl J Med 1992; 327(2): 99.
49. Kutsogiannis DJ, Crowther MA, Lazarovits AI. Granulocyte macrophage colony-stimulating factor for the therapy of cytomegalovirus and ganciclovir-induced leukopenia in a renal transplant recipient. Transplantation 1992; 53: 930.
50. Gordon MS, O'Donell JA, Mohler ER III, Cooper MA. The use of granulocyte colony-stimulating factor in the treatment of fever and neutropenia in a heart transplant patient. J Heart Lung Transplant 1993; 23: 1369.
51. Colquhoun SD, Shaked A, Jurim O, Colonna JO, Rosove MH, Busuttil RW. Reversal of neutropenia with granulocyte colony-stimulating factor without precipitating liver allograft rejection. Transplantation 1993; 56: 1593.
52. Patel HD, Anderson JR, Duncombe AS, Carrington D, Murday A. Granulocyte colony-stimulating factor: a new application for cytomegalovirus-induced neutropenia in cardiac allograft recipients. Transplantation 1994; 58: 863.
53. Peddi VR, Hariharan S, Schroeder TJ, First MR. Role of granulocyte colony stimulating factor (G-CSF) in reversing neutropenia in renal allograft recipients. Clin Transplant 1996; 10: 20.
54. Foster PF, Sankary HN, McChesney LP, et al. The use of granulocyte colony-stimulating factor after liver transplantation. Transplantation 1995; 59: 1557.